Hiroshi Wada - Concepedia

Author

Hiroshi Wada

Also Known As

H Wada, H. Wada, H., Wada, HIROSHI WADA, Hiroshi WADA, Hiroshi Wada, Hiroshi Wada (17388), Koichi Tachibana, Wada, H., Wada, Hiroshi

769

Publications

13.3K

Citations

H-Index

276

Concepts

All Affiliations

The University of Osaka Jichi Medical University Jichi Medical University Saitama Medical Center Osaka International Cancer Institute Kitasato University

About

Hiroshi Wada is an author at The University of Osaka specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	157	5.6K
2	Public Health	18	29	746
3	Health Sciences	15	22	612
4	Engineering	5	5	202
5	Natural Sciences	1	1	14

Hiroshi Wada

319

Publications

12K

Citations

H-Index

Page 1

	Year	Citations
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma Yoshito Tomimaru, Hidetoshi Eguchi, Hiroaki Nagano, Journal of Hepatology Tumor BiologyHepatocellular CarcinomaMedicinePathologySmall Rna	2011	357
MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma Manabu Mikamori, Daisaku Yamada, Hidetoshi Eguchi, Scientific Reports	2017	255
Prevalence and Prognostic Impact of the Coexistence of Multiple Frailty Domains in Elderly Patients with Heart Failure: The FRAGILE-HF Cohort Study Yuya Matsue, Kentaro Kamiya, Hiroshi Saito, European Journal of Heart Failure	2020	254
Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis Masaki Shimizu, Tadafumi Yokoyama, Ken‐ichi Yamada, Lara D. Veeken	2010	246
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial Kohei Nakachi, Masafumi Ikeda, Masaru Konishi, The Lancet Surgical OncologyGastrointestinal OncologyMedicineBiliary CancerGastroenterology	2023	214
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection Yubo Yang, Hiroaki Nagano, Hideo Ôta, Surgery Surgical OncologyHepatologyMedicineCurative ResectionSurgical Pathology	2007	208
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells Yoshito Tomimaru, Hidetoshi Eguchi, Hiroaki Nagano, British Journal of Cancer	2010	175
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction Masaaki Konishi, Nobuyuki Kagiyama, Kentaro Kamiya, European Journal of Preventive Cardiology	2020	169
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression Hideo Ôta, Hiroaki Nagano, Masato Sakon, British Journal of Cancer	2005	148
Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma William A. Michaud, Anthony C. Nichols, Edmund A. Mroz, Clinical Cancer Research	2009	148

Page 1